A detailed history of Met Life Investment Management, LLC transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 11,739 shares of LMAT stock, worth $1.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,739
Previous 10,419 12.67%
Holding current value
$1.02 Million
Previous $691,000 39.65%
% of portfolio
0.01%
Previous 0.0%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$62.62 - $83.59 $82,658 - $110,338
1,320 Added 12.67%
11,739 $965,000
Q1 2024

May 14, 2024

BUY
$54.0 - $71.06 $562,626 - $740,374
10,419 New
10,419 $691,000
Q3 2023

May 09, 2024

BUY
$53.45 - $67.01 $28,916 - $36,252
541 Added 5.48%
10,419 $567,000
Q2 2023

Apr 29, 2024

BUY
$50.38 - $68.21 $524,909 - $710,679
10,419 New
10,419 $700,000
Q2 2023

Aug 10, 2023

BUY
$50.38 - $68.21 $27,255 - $36,901
541 Added 5.48%
10,419 $700,000
Q1 2023

May 09, 2024

BUY
$44.73 - $51.68 $441,842 - $510,495
9,878 New
9,878 $508 Million
Q2 2022

May 10, 2024

SELL
$39.05 - $47.85 $86,456 - $105,939
-2,214 Reduced 18.31%
9,878 $449,000
Q2 2022

Mar 22, 2023

SELL
$39.05 - $47.85 $86,456 - $105,939
-2,214 Reduced 18.31%
9,878 $449,000
Q2 2022

Aug 11, 2022

SELL
$39.05 - $47.85 $86,456 - $105,939
-2,214 Reduced 18.31%
9,878 $450,000
Q1 2022

May 10, 2024

BUY
$40.48 - $51.5 $489,484 - $622,738
12,092 New
12,092 $561,000
Q1 2022

Jun 20, 2023

BUY
$40.48 - $51.5 $89,622 - $114,021
2,214 Added 22.41%
12,092 $561,000
Q1 2022

Mar 22, 2023

BUY
$40.48 - $51.5 $179,771 - $228,711
4,441 Added 58.04%
12,092 $561,000
Q1 2022

May 12, 2022

BUY
$40.48 - $51.5 $179,771 - $228,711
4,441 Added 58.04%
12,092 $562,000
Q4 2021

Jun 21, 2023

SELL
$46.66 - $56.25 $103,911 - $125,268
-2,227 Reduced 22.55%
7,651 $384,000
Q3 2021

Jun 21, 2023

SELL
$53.09 - $60.57 $118,231 - $134,889
-2,227 Reduced 22.55%
7,651 $406,000
Q2 2021

Jun 21, 2023

SELL
$47.74 - $63.33 $106,316 - $141,035
-2,227 Reduced 22.55%
7,651 $466,000
Q1 2021

May 17, 2024

SELL
$40.19 - $51.5 $111,245 - $142,552
-2,768 Reduced 26.57%
7,651 $373,000
Q1 2021

Jun 26, 2023

SELL
$40.19 - $51.5 $89,503 - $114,690
-2,227 Reduced 22.55%
7,651 $373 Million
Q4 2020

Jun 22, 2023

SELL
$31.44 - $41.27 $70,016 - $91,908
-2,227 Reduced 22.55%
7,651 $309,000
Q3 2020

Jun 26, 2023

SELL
$25.73 - $33.98 $57,300 - $75,673
-2,227 Reduced 22.55%
7,651 $248,000
Q2 2020

May 24, 2024

SELL
$22.88 - $30.71 $63,331 - $85,005
-2,768 Reduced 26.57%
7,651 $202 Million
Q2 2020

Jun 26, 2023

SELL
$22.88 - $30.71 $50,953 - $68,391
-2,227 Reduced 22.55%
7,651 $201,000
Q1 2020

Jul 12, 2023

SELL
$21.03 - $38.46 $46,833 - $85,650
-2,227 Reduced 22.55%
7,651 $190,000
Q4 2019

Jul 12, 2023

SELL
$31.27 - $36.21 $69,638 - $80,639
-2,227 Reduced 22.55%
7,651 $275,000
Q3 2019

Jul 12, 2023

SELL
$27.91 - $35.78 $62,155 - $79,682
-2,227 Reduced 22.55%
7,651 $261,000
Q2 2019

Jul 12, 2023

SELL
$25.55 - $30.79 $56,899 - $68,569
-2,227 Reduced 22.55%
7,651 $214,000
Q1 2019

Jul 13, 2023

SELL
$22.45 - $31.55 $49,996 - $70,261
-2,227 Reduced 22.55%
7,651 $237,000
Q4 2018

Jul 13, 2023

SELL
$22.01 - $37.23 $49,016 - $82,911
-2,227 Reduced 22.55%
7,651 $180,000
Q4 2018

Mar 22, 2023

SELL
$22.01 - $37.23 $97,746 - $165,338
-4,441 Reduced 36.73%
7,651 $180,000
Q4 2018

Feb 14, 2019

SELL
$22.01 - $37.23 $97,746 - $165,338
-4,441 Reduced 36.73%
7,651 $181,000
Q3 2018

Jul 13, 2023

SELL
$34.02 - $38.74 $75,762 - $86,273
-2,227 Reduced 22.55%
7,651 $296,000
Q3 2018

Mar 22, 2023

BUY
$34.02 - $38.74 $75,320 - $85,770
2,214 Added 22.41%
12,092 $468,000
Q3 2018

Nov 14, 2018

BUY
$34.02 - $38.74 $151,082 - $172,044
4,441 Added 58.04%
12,092 $468,000
Q4 2017

Feb 15, 2018

BUY
$30.9 - $39.01 $236,415 - $298,465
7,651
7,651 $244,000

Others Institutions Holding LMAT

About LEMAITRE VASCULAR INC


  • Ticker LMAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 21,962,900
  • Market Cap $1.92B
  • Description
  • LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...
More about LMAT
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.